Meta-analysis has shown that ERCC1 expression is associated with the efficacy of platinum-based chemoradiotherapy for head and neck squamous cell carcinoma as well as prognosis of the Asian population; meanwhile, Asians with low ERCC1 expression show better OS and PFS [22–24]. This evidence concerns the gene ERCC1 and head and neck squamous cell carcinoma.